Regulatory News
Monday, January 23, 2017
BRIEF-Elite reports on SequestOx FDA end-of-review meeting
* Elite Pharmaceuticals -To proceed immediately to complete
in vitro and in vivo bridging studies required and expects to
resubmit SequestOx application later this year
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment